Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx

NCT04935177 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation in Highly Sensitized Patients

Interventions

DRUG: Imlifidase
PROCEDURE: PLEX
DRUG: IVIg
DRUG: Anti-CD20 antibodies
DRUG: Eculizumab
OTHER: Remain on wait list

Sponsor

Hansa Biopharma AB